Drug discovery

#Drug discovery #Lab space #UK #UK economy

Lack of lab space hindering growth in the UK, report finds  

The UK must build more laboratory space if it is to meet its global ambitions of becoming a scientific leader, property firms and estate agencies have argued.  A report published by British Land and Savills states that there is a severe shortage of laboratory space to meet… Read More

#News

#Alzheimer's #Drug discovery #Neurology #Stem cells

bit.bio launches stem cell line for neuro research and screening  

Biotechnology company bit.bio has launched a range of immune cells to provide researchers with a consistently functional and rapid human in vitro model for the study of neuroinflammation and neurodegenerative diseases.  The company’s ioMicroglia cell range is designed to recapitulate key human microglia functions and… Read More

#News

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

New DDW Highlights podcast: 20 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The breaking news this week was certainly the first regulatory approval for… Read More

#News

#DNA #Drug discovery #Synthetic biology

Unlocking the potential of synthetic DNA 

Raquel Sanches-Kuiper, Vice President of Science and Applications at Evonetix, and Clare Whitewoods, Marketing Communications Manager at Evonetix, look at the benefits synthetic DNA brings to pharmaceutical development.  Engineering biology is reshaping the world, from enabling the rapid development of vaccines to providing alternatives to petroleum… Read More

#Exclusive Content

#Data #Drug development #Drug discovery #Sustainability

Pistoia Alliance sets out strategic priorities in key areas of R&D  

The Pistoia Alliance has announced four new strategic priorities that will enable the not-for-profit group to accelerate key areas within R&D.  The Pistoia Alliance has appointed steering committees to lead collaboration in the areas of sustainability, adoption of AI, the use of real-world data and data-driven value. Read More

#News

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

This week in drug discovery (13-17 November) 

News round-up for 13-17 November by DDW Digital Content Editor Diana Spencer. The breaking news this week was certainly the first regulatory approval for Casgevy, not only the first gene therapy approved for sickle cell disease, but also the first therapy to use CRISPR gene editing. Read More

#News

Cytometry
#Drug development #Drug discovery #Mass cytometry #Phenotyping #Preclinical development

Digital Article: Immunophenotyping for targeted drug discovery

A new digital article is now available to download entitled ‘A comprehensive approach to immunophenotyping for targeted drug discovery and development’.  With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies. Download this content-rich digital article to read… Read More

#News

#Drug development #Drug discovery #Mass cytometry #Phenotyping #Preclinical development

A comprehensive approach to immunophenotyping for targeted drug discovery and development

With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies. Download this content-rich digital article to read about considerations for implementing and standardising high-dimensional immune profiling methods into drug development programs. Learn about different applications that demonstrate the robustness and reproducibility of a mass cytometry-based… Read More

#Resources

Samples for chemical analysis
#Bioseparation #Characterisation #Drug development #Drug discovery #LC-MS #Mass spectrometry / NMR

New whitepaper: Unlock hidden isomers in your LC-MS analysis

Feeling isomer FOMO? Download this new whitepaper from MOBILion Systems ‘High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)’. MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of… Read More

#News

#Bioseparation #Characterisation #Drug development #Drug discovery #LC-MS #Mass spectrometry / NMR

Isomer FOMO? Unlock hidden isomers in your LC-MS analysis

MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of complex molecules than traditional methods. Download the whitepaper “High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)” to learn more about:… Read More

#Resources

#Cancer #Cancer research #DDW Turning Science into Business Summit #Drug discovery #Immunotherapy #Oncology

New DDW Highlights episode: 13 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  With the first DDW Turning Science into Business Summit taking… Read More

#News

#Cancer #Cancer research #DDW Turning Science into Business Summit #Drug discovery #Immunotherapy #Oncology

This week in drug discovery (6-10 November) 

News round-up for 6-10 November by DDW Digital Content Editor Diana Spencer. With the first DDW Turning Science into Business Summit taking place next week on the theme of Cancer Research, this dynamic area of drug discovery is my round-up focus again. Most… Read More

#News

#Drug discovery #Histology #Histopathologic testing #Meet the Researcher #Virscio

Meet the researcher: Richard Bouffard, Virscio

DDW’s Megan Thomas looks at a day in the life of Richard Bouffard, Histology Director at Virscio.  MT: Where do you work, and can you tell us what you’re working on at the moment? RB: I’m the Histology Director of the histology lab that performs subsequent histopathologic testing and… Read More

#Exclusive Content

Protein degrader
#Cancer research #Drug discovery #PROTAC #Protein degradation #Webinar

Webinar: Bring successful protein degraders to the clinic

A new webinar ‘Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift‘, brought to you by NanoTemper, is now available to watch on-demand. As more and more R&D pipelines include PROTAC candidates — the race to bring successful and… Read More

Webinar date:
#News

#Cancer research #Drug discovery #PROTAC #Protein degradation #Webinar

Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift

As more and more R&D pipelines include PROTAC candidates — the race to bring successful and efficient protein degraders to the clinic is on. These targets present challenges in the biophysical characterisation of binary and ternary complexes, making developing effective degraders complicated. Watch this on-demand webinar to learn: How Spectral… Read More

Webinar date:
Brought to you by NanoTemper
#Webinars

#Cancer #Cancer drug targets #Clinical trials #Drug discovery #Psychedelics

New DDW Highlights podcast: 6 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news highlights this week feature a variety of exciting clinical trial… Read More

#News